Deep Tech Startups

Deepwave Digital designs AI-driven RF, wireless, and edge computing systems for real-time signal classification, detection, and spectrum intelligence. It serves defense, aerospace, telecommunications, government, and research customers with custom silicon, software-defined radio integration, and embedded AI platforms.

1 investor

Deeyook develops firmware-based positioning technology that uses patented wireless interferometry to extract sub-meter location data from existing Wi-Fi signals, working indoors and outdoors without GPS or added hardware. It provides a spatial awareness layer for Physical AI, serving autonomous systems, devices, and connected environments.

1 investor

Defined Bioscience develops cell culture media, growth factors, and related reagents for stem cell biology and regenerative medicine research. The company supplies branded products for laboratory and research use.

1 investor

Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.

1 investor

Dehidden builds consumer applications and AI research across areas like intelligent agents and personalized virtual worlds, and offers development and advisory services. It operates three arms — Labs (AI research), Studio (architecture, integration, and development support), and Counsel (strategic and technical guidance for founders).

1 investor

Delft Circuits manufactures turn-key loaders and probes for large-scale systems, along with compact cabling kits designed for customer self-installation. All products are designed, manufactured, assembled, and tested in-house.

1 investor

Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.

1 investor

DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.

1 investor

Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells inside patients (in vivo) for cell and gene therapies, using programmable targeting to transport payloads such as DNA and mRNA to specific cell types. Its first product targets T-cells to deliver a CAR gene for cancer immunotherapy, with longer-term applications in autoimmune, neurodegenerative, and cardiovascular diseases.

1 investor

Delman offers a self-service analytics platform that generates interactive, customizable dashboards with real-time data from sales, marketing, operations, or finance datasets. It is aimed at business and data teams for reporting, forecasting, and performance monitoring, with cloud, hybrid, or on-premise deployment.

1 investor

Delox develops proprietary bio-decontamination solutions using solid-formulated hydrogen peroxide technology for healthcare, pharmaceutical, laboratory, and industrial environments where contamination control is critical. The company operates across Europe and North America, serving organizations in highly controlled settings that require precision decontamination with zero tolerance for failure.

1 investor

Delphisonic offers DS-Insight, software that turns real-time sensor data into dashboards, alerts, and AI-driven predictive analytics for monitoring asset health and enabling predictive maintenance. It serves industrial operators, engineers, and managers, integrating with ERP, MES, SCADA, and DS-X Cloud platforms.

1 investor

Delta Black Aerospace designs and manufactures the RAIDER 330, a hybrid-electric unmanned aerial system for military and defense applications. The system combines vertical takeoff and landing capabilities with extended endurance and modular payload capacity for intelligence, surveillance, and reconnaissance missions.

1 investor

Delta Life Science develops rapid, sensitive, and low-cost biosensor technology and instruments for analyzing biomarker concentrations in life sciences research and diagnostics. The company, which originated from TNO research, serves academic institutions and the pharmaceutical industry with tools for biomolecular interaction analysis.

1 investor

DeltaSpark builds a containerized, patented electrocatalytic system that connects downstream of carbon capture equipment to mineralize CO₂ into solid carbonates while producing clean hydrogen and oxygen on-site. It targets hard-to-abate industries such as cement, waste-to-energy, and heavy manufacturing, with carbonate byproducts usable for green concrete and construction bricks.

1 investor

Delvitech develops AI-powered 3D optical inspection platforms for electronics manufacturing, specifically for automated optical inspection (AOI) and solder paste inspection (SPI) of printed circuit boards. The company combines Swiss engineering principles with proprietary neural networks to help manufacturers reduce defects, waste, and environmental impact.

1 investor

Demeetra is a genome engineering company that develops precision gene-editing platforms — including Cas-CLOVER, Harbor-IN and Super piggyBac transposases and CleanCut CHO host cell lines — along with integrated cell line development and GMP manufacturing services. It serves biopharmaceutical developers through flexible licensing and service models for cell line development, biomanufacturing, and discovery programs.

1 investor

DENCODA develops DNA-based diagnostic assays that detect enzyme activity to identify diseases including osteoarthritis, kinase-related cancers, and protease-linked conditions. The company serves clinicians, researchers, and patients seeking early disease detection and diagnosis.

1 investor

DENKweit develops vision AI technology for industrial quality and data management applications. The company, a Fraunhofer spin-off based in Germany, builds image analysis systems designed to be accessible and deliver practical value across industries.

1 investor

DeNoize develops active noise-cancellation window technology that uses adaptive sound monitoring to reduce urban noise in residential spaces. The company serves homeowners and properties affected by environmental noise, operating in the acoustic comfort and sustainable building technology sector.

1 investor

DenovAI Biotech uses artificial intelligence and computational molecular biophysics to design proteins de novo, building platforms for rapid antibody discovery and bespoke high-affinity binders. The company targets therapeutic and diagnostic applications, including antibodies, peptide biologics, and diagnostic reporters for drug discovery.

1 investor

Deorbital Devices provides satellite delivery, orbital transportation, and space waste management services. The company operates launch and deployment missions using proprietary orbital transfer vehicles to support space logistics infrastructure.

1 investor

Deployable Energy designs and manufactures nuclear microreactors intended for scalable, rapid deployment across diverse applications including remote operations and maritime platforms. The company produces the Unity™ microreactor, a 1 MWe nuclear battery engineered for manufacturability and reliability using standard fuels and processes.

1 investor

DerekNet develops software solutions for oil and gas operators, providing virtual flow metering through machine learning models and production measurement management. The company offers NeuroNet for building data-driven virtual meters and DerekSuite for production measurement, allocation, and accounting across the full hydrocarbon supply chain.

1 investor